Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michel Gougeon is active.

Publication


Featured researches published by Michel Gougeon.


Journal of Magnetism and Magnetic Materials | 2010

Large specific absorption rates in the magnetic hyperthermia properties of metallic iron nanocubes

B. Mehdaoui; Anca Meffre; Lise-Marie Lacroix; J. Carrey; Sébastien Lachaize; Michel Gougeon; M. Respaud; Bruno Chaudret

We report on the magnetic hyperthermia properties of chemically synthesized ferromagnetic 11 and 16 nm Fe(0) nanoparticles of cubic shape displaying the saturation magnetization of bulk iron. The specific absorption rate measured on 16 nm nanocubes is 1690±160 W/g at 300 kHz and 66 mT. This corresponds to specific losses-per-cycle of 5.6 mJ/g, largely exceeding the ones reported in other systems. A way to quantify the degree of optimization of any system with respect to hyperthermia applications is proposed. Applied here, this method shows that our nanoparticles are not fully optimized, probably due to the strong influence of magnetic interactions on their magnetic response. Once protected from oxidation and further optimized, such nano-objects could constitute efficient magnetic cores for biomedical applications requiring very large heating power.


ACS Nano | 2014

Targeting a G-Protein-Coupled Receptor Overexpressed in Endocrine Tumors by Magnetic Nanoparticles To Induce Cell Death

Claire Sanchez; Darine El Hajj Diab; Vincent Connord; Pascal Clerc; Etienne Meunier; Bernard Pipy; Bruno Payré; Reasmey P. Tan; Michel Gougeon; J. Carrey; Véronique Gigoux; Daniel Fourmy

Nanotherapy using targeted magnetic nanoparticles grafted with peptidic ligands of receptors overexpressed in cancers is a promising therapeutic strategy. However, nanoconjugation of peptides can dramatically affect their properties with respect to receptor recognition, mechanism of internalization, intracellular trafficking, and fate. Furthermore, investigations are needed to better understand the mechanism whereby application of an alternating magnetic field to cells containing targeted nanoparticles induces cell death. Here, we designed a nanoplatform (termed MG-IONP-DY647) composed of an iron oxide nanocrystal decorated with a ligand of a G-protein coupled receptor, the cholecystokinin-2 receptor (CCK2R) that is overexpressed in several malignant cancers. MG-IONP-DY647 did not stimulate inflammasome of Raw 264.7 macrophages. They recognized cells expressing CCK2R with a high specificity, subsequently internalized via a mechanism involving recruitment of β-arrestins, clathrin-coated pits, and dynamin and were directed to lysosomes. Binding and internalization of MG-IONP-DY647 were dependent on the density of the ligand at the nanoparticle surface and were slowed down relative to free ligand. Trafficking of CCK2R internalized with the nanoparticles was slightly modified relative to CCK2R internalized in response to free ligand. Application of an alternating magnetic field to cells containing MG-IONP-DY647 induced apoptosis and cell death through a lysosomal death pathway, demonstrating that cell death is triggered even though nanoparticles of low thermal power are internalized in minute amounts by the cells. Together with pioneer findings using iron oxide nanoparticles targeting tumoral cells expressing epidermal growth factor receptor, these data represent a solid basis for future studies aiming at establishing the proof-of-concept of nanotherapy of cancers using ligand-grafted magnetic nanoparticles specifically internalized via cell surface receptors.


Journal of Applied Physics | 2010

Magnetic anisotropy determination and magnetic hyperthermia properties of small Fe nanoparticles in the superparamagnetic regime

B. Mehdaoui; Anca Meffre; Lise-Marie Lacroix; J. Carrey; Sébastien Lachaize; M. Respaud; Michel Gougeon; Bruno Chaudret

We report on the magnetic and hyperthermia properties of 5.5 nm in diameter iron nanoparticles synthesized by organometallic chemistry, which display the bulk magnetization. Quantitative analysis of alternative susceptibility measurements allows the determination of the effective anisotropy Keff=1.3×105 J m−3. Hyperthermia measurements are performed at a magnetic field up to 66 mT and at frequencies in the range of 5–300 kHz. Maximum measured specific absorption rate (SAR) is 280 W/g. SAR displays a square dependence with the magnetic field below 30 mT but deviates from this power law at higher value. SAR is linear with the applied frequency for μ0H=19 mT. These results are discussed in the light of linear response theory.


Journal of Controlled Release | 2018

Targeted Magnetic Intra-Lysosomal Hyperthermia produces lysosomal reactive oxygen species and causes Caspase-1 dependent cell death

Pascal Clerc; Pauline Jeanjean; Nicolas Hallali; Michel Gougeon; Bernard Pipy; J. Carrey; Daniel Fourmy; Véronique Gigoux

Abstract Therapeutic strategies using drugs which cause Lysosomal Cell Death have been proposed for eradication of resistant cancer cells. In this context, nanotherapy based on Magnetic Intra‐Lysosomal Hyperthermia (MILH) generated by magnetic nanoparticles (MNPs) that are grafted with ligands of receptors overexpressed in tumors appears to be a very promising therapeutic option. However, mechanisms whereby MILH induces cell death are still elusive. Herein, using Gastrin‐grafted MNPs specifically delivered to lysosomes of tumor cells from different cancers, we provide evidences that MILH causes cell death through a non‐apoptotic signaling pathway. The mechanism of cell death involves a local temperature elevation at the nanoparticle periphery which enhances the production of reactive oxygen species through the lysosomal Fenton reaction. Subsequently, MILH induces lipid peroxidation, lysosomal membrane permeabilization and leakage of lysosomal enzymes into the cytosol, including Cathepsin‐B which activates Caspase‐1 but not apoptotic Caspase‐3. These data highlight the clear potential of MILH for the eradication of tumors overexpressing receptors. Graphical abstract Figure. No Caption available.


Inorganic Chemistry | 2017

Bi2(C2O4)3·7H2O and Bi(C2O4)OH Oxalates Thermal Decomposition Revisited. Formation of Nanoparticles with a Lower Melting Point than Bulk Bismuth

Pierre Roumanille; Valérie Baco-Carles; Corine Bonningue; Michel Gougeon; Benjamin Duployer; Philippe Monfraix; Hoa Le Trong; Philippe Tailhades

Two bismuth oxalates, namely, Bi2(C2O4)3·7H2O and Bi(C2O4)OH, were studied in terms of synthesis, structural characterization, particle morphology, and thermal behavior under several atmospheres. The oxalate powders were produced by chemical precipitation from bismuth nitrate and oxalic acid solutions under controlled pH, then characterized by X-ray diffraction (XRD), temperature-dependent XRD, IR spectroscopy, scanning electron microscopy, and thermogravimetric differential thermal analyses. New results on the thermal decomposition of bismuth oxalates under inert or reducing atmospheres are provided. On heating in nitrogen, both studied compounds decompose into small bismuth particles. Thermal properties of the metallic products were investigated. The Bi(C2O4)OH decomposition leads to a Bi-Bi2O3 metal-oxide composite product in which bismuth is confined in a nanometric size, due to surface oxidation. The melting point of such bismuth particles is strongly related to their crystallite size. The nanometric bismuth melting has thus been evidenced ∼40 °C lower than for bulk bismuth. These results should contribute to the development of the oxalate precursor route for low-temperature soldering applications.


Advanced Functional Materials | 2011

Optimal Size of Nanoparticles for Magnetic Hyperthermia: A Combined Theoretical and Experimental Study

B. Mehdaoui; Anca Meffre; J. Carrey; Sébastien Lachaize; Lise-Marie Lacroix; Michel Gougeon; Bruno Chaudret; M. Respaud


Archive | 1989

Composition comprising an oxide with a spinel structure, its use as a catalyst and process for obtaining it.

Abel Rousset; Belaid Maachi; Bernard Gilot; Michel Gougeon


Archive | 1988

γ-Fe2 O3 /Fe3 O4 spinels

Abel Rousset; Belaid Maachi; Bernard Gilot; Michel Gougeon


Archive | 2011

Procede de fabrication d'un dispositif comprenant des brasures realisees a partir d'oxalate metallique

Olivier Vendier; Lidwine Raynaud; Valérie Baco; Michel Gougeon; Trong Hoa Le; Philippe Tailhades


Solid State Sciences | 2017

Paramagnetic behaviour of silver nanoparticles generated by decomposition of silver oxalate

Hoa Le Trong; Kateryna Kiryukhina; Michel Gougeon; Valérie Baco-Carles; Frédéric Courtade; Sophie Dareys; Philippe Tailhades

Collaboration


Dive into the Michel Gougeon's collaboration.

Top Co-Authors

Avatar

Philippe Tailhades

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Abel Rousset

Paul Sabatier University

View shared research outputs
Top Co-Authors

Avatar

J. Carrey

University of Toulouse

View shared research outputs
Top Co-Authors

Avatar

Trong Hoa Le

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Valérie Baco

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Anca Meffre

University of Toulouse

View shared research outputs
Top Co-Authors

Avatar

B. Mehdaoui

University of Toulouse

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Respaud

University of Toulouse

View shared research outputs
Researchain Logo
Decentralizing Knowledge